COMP <GO>
NSP vs ASTH // RETURN ON INVESTED CAPITAL (ROIC)
Insperity Inc. (NYSE) VS. Astrana Health Inc. (NASDAQ) • 15-METRIC TALLY: NSP 1
— ASTH 8
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: ASTH
LAST: $46.29 (-10.38%) • MKT CAP: $1.77B
roic
-8.90%
LAST: $36.62 (-0.14%) • MKT CAP: $1.82B
roic
4.60%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NSP VS. ASTH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NSP | ASTH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 13.20% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -8.90% | 4.60% | -13.50 | ASTH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 27.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -17.48% | 5.75% | -23.23 | ASTH | /fcf-yield <GO> |
| Operating Margin | -0.10% | 2.50% | -2.60 | ASTH | /operating-margins <GO> |
| Net Profit Margin | -0.10% | 0.80% | -0.90 | ASTH | /net-margins <GO> |
| Revenue Growth (YoY) | 3.50% | 56.40% | -52.90 | ASTH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 5.09% | 0.43% | +4.66 | NSP | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 2.54 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 6/9 | -5.00 | ASTH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.3 | 46.7 | -0.45 | ASTH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 63.6x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.77B | $1.82B | -$48.5M | ASTH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NSP REV | ASTH REV | NSP GROSS % | ASTH GROSS % | NSP FCF | ASTH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $6.81B | $3.18B | 13.2% | — | -$309.0M | $104.5M |
| FY 2024 | $6.58B | $2.03B | 16.0% | — | $482.0M | $44.2M |
| FY 2023 | $6.49B | $1.39B | — | — | $198.0M | $68.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NSP // BETA —
ASTH // BETA —